SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination

Rapid spread of SARS-CoV-2 variants C.1.2 and B.1.621 (Mu variant) in Africa and the Americas, respectively, as well as a high number of mutations in the viral spike proteins raised concerns that these variants might pose an elevated threat to human health. Here, we show that C.1.2 and B.1.621 spike...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Prerna, Kempf, Amy, Nehlmeier, Inga, Graichen, Luise, Winkler, Martin S., Lier, Martin, Schulz, Sebastian, Jäck, Hans-Martin, Cossmann, Anne, Stankov, Metodi V., Behrens, Georg M.N., Pöhlmann, Stefan, Hoffmann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010234/
https://www.ncbi.nlm.nih.gov/pubmed/35477025
http://dx.doi.org/10.1016/j.celrep.2022.110754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010234/
https://www.ncbi.nlm.nih.gov/pubmed/35477025
http://dx.doi.org/10.1016/j.celrep.2022.110754

Ejemplares similares